
Mineralys Therapeutics, Inc.: shareholders and insiders
Price
$13.66
November 20, 2026Market cap $1.2B
What Ploutos Investor adds for Mineralys Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 4 fiscal years, from 2022
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Catalys Pacific Fund, LPwith 3 more personsShare of class10.1%
- RA Capital Management, L.P.with 3 more personsShare of class9.90%
- Samsara BioCapital, L.P.with 4 more personsShare of class8.20%
- BlackRock, Inc.Share of class5.20%
- FMRwith 1 more personShare of class5.10%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Catalys Pacific Fund, LPwith 3 more persons | 10.1% | 8.00M | Feb 13, 20262 filings since Aug 14, 2025 | 13G/A | |
| RA Capital Management, L.P.with 3 more persons | 9.90% | 7.80M | Sep 8, 20252 filings since Mar 17, 2025 | 13D/A | |
| Samsara BioCapital, L.P.with 4 more persons | 8.20% | 6.35M | Sep 8, 20252 filings since Mar 17, 2025 | 13D/A | |
| BlackRock, Inc. | 5.20% | 4.11M | Jan 21, 2026 | 13G | |
| FMRwith 1 more person | 5.10% | 4.46M | Aug 6, 20262 filings since Feb 5, 2026 | 13G/A |
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter
- Millennium Mgmt (Englander)In the quarter-42%
- Renaissance TechnologiesIn the quarter+10%
- Citadel Advisors (Griffin)In the quarter-44%
- D.E. ShawIn the quarter-28%
- AQR CapitalIn the quarter-8.0%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 1.27M | $32M | 0.05% | |
| Millennium Mgmt (Englander) | 708.4K | -42% | $18M | 0.01% |
| Renaissance Technologies | 417.1K | +10% | $11M | 0.01% |
| Citadel Advisors (Griffin) | 263.3K | -44% | $6.6M | 0.00% |
| D.E. Shaw | 255.0K | -28% | $6.4M | 0.00% |
| AQR Capital | 140.4K | -8.0% | $3.5M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 8.40% of its shares outstanding were held short, -4.7% since the report before.
- Shares held short
- 7.44M
- 8.40%
- Since the report before7.81M on Sep 30, 2026
- -4.7%
- 5.3
- 1.40M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 64%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 1.41M
- Nov 15, 2023: Shares held short 1.28M
- Nov 30, 2023: Shares held short 1.20M
- Dec 15, 2023: Shares held short 625.1K
- Dec 29, 2023: Shares held short 990.6K
- Jan 12, 2024: Shares held short 836.9K
- Jan 31, 2024: Shares held short 810.4K
- Feb 15, 2024: Shares held short 965.5K
- Feb 29, 2024: Shares held short 974.0K
- Mar 15, 2024: Shares held short 842.1K
- Mar 28, 2024: Shares held short 850.5K
- Apr 15, 2024: Shares held short 872.9K
- Apr 30, 2024: Shares held short 1.01M
- May 15, 2024: Shares held short 949.7K
- May 31, 2024: Shares held short 920.3K
- Jun 14, 2024: Shares held short 904.7K
- Jun 28, 2024: Shares held short 1.14M
- Jul 15, 2024: Shares held short 1.56M
- Jul 31, 2024: Shares held short 1.51M
- Aug 15, 2024: Shares held short 1.45M
- Aug 30, 2024: Shares held short 1.56M
- Sep 13, 2024: Shares held short 1.47M
- Sep 30, 2024: Shares held short 1.59M
- Oct 15, 2024: Shares held short 1.61M
- Oct 31, 2024: Shares held short 1.39M
- Nov 15, 2024: Shares held short 1.30M
- Nov 29, 2024: Shares held short 1.41M
- Dec 13, 2024: Shares held short 1.59M
- Dec 31, 2024: Shares held short 1.83M
- Jan 15, 2025: Shares held short 1.87M
- Jan 31, 2025: Shares held short 1.86M
- Feb 14, 2025: Shares held short 1.75M
- Feb 28, 2025: Shares held short 2.01M
- Mar 14, 2025: Shares held short 2.22M
- Mar 31, 2025: Shares held short 4.71M
- Apr 15, 2025: Shares held short 6.09M
- Apr 30, 2025: Shares held short 6.43M
- May 15, 2025: Shares held short 7.21M
- May 30, 2025: Shares held short 6.16M
- Jun 13, 2025: Shares held short 6.17M
- Jun 30, 2025: Shares held short 7.67M
- Jul 15, 2025: Shares held short 7.87M
- Jul 31, 2025: Shares held short 7.00M
- Aug 15, 2025: Shares held short 7.41M
- Aug 29, 2025: Shares held short 7.62M
- Sep 15, 2025: Shares held short 7.58M
- Sep 30, 2025: Shares held short 6.88M
- Oct 15, 2025: Shares held short 7.13M
- Oct 31, 2025: Shares held short 6.84M
- Nov 14, 2025: Shares held short 6.89M
- Nov 28, 2025: Shares held short 7.41M
- Dec 15, 2025: Shares held short 7.95M
- Dec 31, 2025: Shares held short 9.24M
- Jan 15, 2026: Shares held short 10.30M
- Jan 30, 2026: Shares held short 10.10M
- Feb 13, 2026: Shares held short 9.98M
- Feb 27, 2026: Shares held short 9.61M
- Mar 13, 2026: Shares held short 8.95M
- Mar 31, 2026: Shares held short 8.37M
- Apr 15, 2026: Shares held short 8.78M
- Apr 30, 2026: Shares held short 8.53M
- May 15, 2026: Shares held short 9.02M
- May 29, 2026: Shares held short 9.48M
- Jun 15, 2026: Shares held short 8.70M
- Jun 30, 2026: Shares held short 11.10M
- Jul 15, 2026: Shares held short 9.55M
- Jul 31, 2026: Shares held short 9.31M
- Aug 14, 2026: Shares held short 9.65M
- Aug 31, 2026: Shares held short 9.33M
- Sep 15, 2026: Shares held short 9.18M
- Sep 30, 2026: Shares held short 7.81M
- Oct 15, 2026: Shares held short 7.44M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading25.2% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 25.2% of the shares in the reported trades were short sales, against 30.1% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 25.2%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 30.1%
- Change
- -4.9 pts
- Short sales a dayon average, of 691.1K shares
- 173.8K
- More than atof 3,666 US-listed companies, same days
- 2%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 41%
- Oct 15, 2026: Short sales 67.6%
- Oct 16, 2026: Short sales 58.9%
- Oct 19, 2026: Short sales 45.2%
- Oct 20, 2026: Short sales 44.6%
- Oct 21, 2026: Short sales 54.8%
- Oct 22, 2026: Short sales 55.3%
- Oct 23, 2026: Short sales 46.3%
- Oct 26, 2026: Short sales 23.4%
- Oct 27, 2026: Short sales 15%
- Oct 28, 2026: Short sales 30.6%
- Oct 29, 2026: Short sales 18.5%
- Oct 30, 2026: Short sales 15%
- Nov 2, 2026: Short sales 19.9%
- Nov 3, 2026: Short sales 18%
- Nov 4, 2026: Short sales 19.8%
- Nov 5, 2026: Short sales 33.8%
- Nov 6, 2026: Short sales 29.7%
- Nov 9, 2026: Short sales 16.9%
- Nov 10, 2026: Short sales 26.3%
- Nov 11, 2026: Short sales 21.6%
- Nov 12, 2026: Short sales 24.9%
- Nov 13, 2026: Short sales 14.3%
- Nov 16, 2026: Short sales 32.4%
- Nov 17, 2026: Short sales 27.1%
- Nov 18, 2026: Short sales 34.7%
- Nov 19, 2026: Short sales 39.9%
- Nov 20, 2026: Short sales 45.8%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund0.71%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.49%
- IBBiShares Biotechnology ETFWeight in the fund0.13%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.09%
- IWMiShares Russell 2000 ETFWeight in the fund0.05%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.05%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.03%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.03%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.02%
- VXFVanguard Extended Market Index FundWeight in the fund0.02%
19 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 193
- Q4 2025: Managers 223
- Q1 2026: Managers 217
- Q2 2026: Managers 226
Institutional investors by quarter
The fund managers holding MLYS, quarter by quarter, from Q1 2023 to Q2 2025, 10 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 226 managers held 100M shares, worth $2.7B. During the quarter 36 opened a position, 27 closed one, 85 added and 64 trimmed.
The largest holders, Q2 2026
- Catalys PacificIn the quarter
- Ra Capital ManagementIn the quarter
- BlackRockIn the quarter+31%
- Samsara BiocapitalIn the quarter
- FMRIn the quarter-7.2%
- State StreetIn the quarter+41%
- Deerfield ManagementIn the quarter
- Vanguard Capital ManagementIn the quarter+12%
- Laurion Capital ManagementIn the quarter+12%
- Price T Rowe AssociatesIn the quarter+68%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Catalys Pacific | 7.90M | $213M | |
| Ra Capital Management | 7.69M | $208M | |
| BlackRock | 5.89M | +31% | $159M |
| Samsara Biocapital | 5.87M | $158M | |
| FMR | 4.51M | -7.2% | $122M |
| State Street | 4.14M | +41% | $112M |
| Deerfield Management | 3.96M | $107M | |
| Vanguard Capital Management | 2.76M | +12% | $74M |
| Laurion Capital Management | 2.51M | +12% | $68M |
| Price T Rowe Associates | 2.26M | +68% | $61M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Mineralys Therapeutics's filings show?
Who buys and sells is one part of Mineralys Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold MLYS?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Point72 (Cohen)'s, worth $32M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.